ArticleMolecular medicine reports2015

Ephrin type‑A receptor 2 regulates sensitivity to paclitaxel in nasopharyngeal carcinoma via the phosphoinositide 3‑kinase/Akt signalling pathway.

Yunyun Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.